ophthalmology

Close-up of human eye

Biotech

Théa pens $280M deal for Iolyx's phase 3-ready eye disease drug

Laboratoires Théa has penned a deal potentially worth up to $280 million to get its hands on Iolyx Therapeutics’ phase 3-ready eye disease drug.

James Waldron Dec 3, 2025 8:25am

eyeball

Precise Bio completes 1st 3D-printed human cornea transplant

Nov 19, 2025 8:30am

Close-up of Benjamin Franklins eyes peering through hundred dollar bills

Lilly bags eye-catching gene therapy in $475M deal

Nov 10, 2025 7:00am

Closeup of blue eye on black background

Italian biotech raises $141M series B to fund eye gene therapies

Nov 3, 2025 3:00am

Close-up of human eye

Science's retinal implant restores some vision in AMD patients

Oct 21, 2025 6:50am

Graphic image of a compass above an unfolded map Orange background color

I-Mab unveils new name, strategy, asset and Hong Kong IPO plans

Oct 17, 2025 10:45am